Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleFocus: Nanotechnology

Nanotechnology: Safety Issues

Kathleen Kenwright and Linda L. Williford Pifer
American Society for Clinical Laboratory Science April 2010, 23 (2) 122-126; DOI: https://doi.org/10.29074/ascls.23.2.122
Kathleen Kenwright
University of Tennessee Health Science Center, Memphis, TN 38163
MS, MT,MP(ASCP) SI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kkenwrig@uthsc.edu
Linda L. Williford Pifer
University of Tennessee Health Science Center, Memphis, TN 38163
Ph.D.,SM(ASCP), GS(ABB)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

  1. Kathleen Kenwright, MS, MT,MP(ASCP) SI⇑
    1. University of Tennessee Health Science Center, Memphis, TN 38163
  2. Linda L. Williford Pifer, Ph.D.,SM(ASCP), GS(ABB)
    1. University of Tennessee Health Science Center, Memphis, TN 38163
  1. Address for Correspondence: Kathleen Kenwright, MS, MT,MP(ASCP), SI, Assistant Professor, Department of Clinical Laboratory Sciences, University of Tennessee Health Science Center, 930 Madison Avenue, Suite 672, Memphis, TN, 38163, 901-448-6338., kkenwrig{at}uthsc.edu
  1. List the “watchdog” organizations and agencies that intend to improve oversight of the safety of nanotechnology development and research.

  2. Describe potential personal risks posed by nanotechnology.

  3. Differentiate between speculation about nanomaterial safety and data-supported “facts”.

  4. List products that contain nanoparticles.

  5. Identify sources of information concerning safety of handling nanotechnology products in the clinical laboratory.

Extract

The Current Ubiquity of Nanotechnology Is nanotechnology safe for humans? Nanoproducts are everywhere. There are currently over 1000 nanotechnology-based consumer products on the market.1,2 An inventory of nanoengineered products is maintained by the Project on Emerging Nanotechnologies (PEN) and published on their web site (Table 1).1

Some products boldly declare nanotechnology in their advertising such as Bionic Joint Support™ “…it's worth taking advantage of a nanosphere liposomal delivery system”3; other manufacturers use nanoparticles but choose not to advertise the fact. Employment of nanoengineered particles in manufacturing is increasing at an enormous rate, but reporting the use of nanomaterials is voluntary. Maynard and Rejeski say these voluntary efforts have been unsuccessful.4 The US Environmental Protection Agency (EPA) stated that “approximately 90% of the different nanoscale materials likely to be commercially available were not reported”.4,5

Consumers are exposed to nanoparticles daily, without even realizing it, from natural sources as they are present in soot and many living and non-living entities in nature. Nanoparticles such as titanium dioxide (TiO2) and zinc oxide are used in sunscreens and cosmetics. Titanium dioxide is also used as a food additive to whiten creamy products such as salad dressings, and it is used in candies and non-dairy creamers.6 Nanomaterials are internalized by ingestion of food, medication or supplements that contain microparticles (Figure 1). Silicates and aluminosilicates are added to food products as an adsorbent to prevent caking. The average person ingests approximately 1012 submicron-sized particles each day in the form of food additives.6

Exposure to Nanomaterials There…

ABBREVIATIONS: FDA= Federal Drug Administration; MSDS= material safety data sheets; ASR= analyte specific reagents; NIOSH = National Institute for Occupational Safety and Health, NIST = National Institute of Standards and Technology; OTC = over-the-counter; NIL= National Information Library; FTC= Federal Trade Commission; CDER= Center for Drug Evaluation and Research; EPA= Environmental Protection Agency; NST= Center for Nanoscale Science and Technology; NTF= Nanotechnology Task Force; PEN = Project on Emerging Technologies.

    INDEX TERMS
  • nanomaterials
  • nanoproducts
  • nanoemulsions
  • nanoparticles
  • Nanotechnology Task Force
  • Project on Emerging Technologies
  • Center for Nanoscale Science and Technology
  • nanotechnology safety
  1. List the “watchdog” organizations and agencies that intend to improve oversight of the safety of nanotechnology development and research.

  2. Describe potential personal risks posed by nanotechnology.

  3. Differentiate between speculation about nanomaterial safety and data-supported “facts”.

  4. List products that contain nanoparticles.

  5. Identify sources of information concerning safety of handling nanotechnology products in the clinical laboratory.

  • ©Copyright 2009 American Society for Clinical Laboratory Science Inc. All rights reserved.
PreviousNext
Back to top

In this issue

American Society for Clinical Laboratory Science: 23 (2)
American Society for Clinical Laboratory Science
Vol. 23, Issue 2
Spring 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nanotechnology: Safety Issues
(Your Name) has sent you a message from American Society for Clinical Laboratory Science
(Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Nanotechnology: Safety Issues
Kathleen Kenwright, Linda L. Williford Pifer
American Society for Clinical Laboratory Science Apr 2010, 23 (2) 122-126; DOI: 10.29074/ascls.23.2.122

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Nanotechnology: Safety Issues
Kathleen Kenwright, Linda L. Williford Pifer
American Society for Clinical Laboratory Science Apr 2010, 23 (2) 122-126; DOI: 10.29074/ascls.23.2.122
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Nanotechnology: Nanomedicine
  • Nanotechnology: Societal and Environmental Impact
Show more Focus: Nanotechnology

Similar Articles

Keywords

  • nanomaterials
  • nanoproducts
  • nanoemulsions
  • nanoparticles
  • Nanotechnology Task Force
  • Project on Emerging Technologies
  • Center for Nanoscale Science and Technology
  • nanotechnology safety

© 2025 The American Society for Clinical Laboratory Science

Powered by HighWire